Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal oxytocin and social support after acute trauma
2011-004177-83Phase 2Terminated
- Sponsor
- Academic Medical Center
- Start
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin in post-traumatic stress disorder (PTSD) (4 arms), sponsored by Academic Medical Center. Primary endpoints: PTSD symptom severity at 1 month and PTSD symptom severity at 3 months. Started Sep 2011; status: terminated.
02
Drugs
oxytocin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on 2011-004177-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004177-83.